<DOC>
	<DOCNO>NCT00148954</DOCNO>
	<brief_summary>RIGHT randomize , prospective , two-arm study assess differential efficacy VITALITY 2 implantable cardioverter defibrillator ( ICDs ) use Rhythm ID™ versus select Medtronic ICDs .</brief_summary>
	<brief_title>RIGHT : Rhythm ID Going Head-to-Head Trial</brief_title>
	<detailed_description>RIGHT compare incidence Ventricular Tachycardia/Fibrillation ( VT/VF ) therapy deliver Supraventricular Tachycardia ( SVT ) episodes use VITALITY 2 device Rhythm ID™ ICDs employ rhythm discrimination algorithm . Appropriateness therapy assess independent adjudication VT/VF event lead therapy . Comparisons make device manufacturer across patient population receive either dual- single-chamber device .</detailed_description>
	<mesh_term>Tachycardia</mesh_term>
	<criteria>Patients meet current indication ICD Patients sign date Patient Informed Consent form prior implant visit Patients remain clinical care enrol physician approved center Patients able tolerate ICD program specifically prescribe study protocol Patients third degree heart block Patients whose life expectancy le 12 month Patients cardiac surgery procedure plan yet perform duration study Patients currently enrol another investigational study registry would directly impact treatment outcome current study Patients young 18 year age Patients mentally incompetent sign Patient Informed Consent form comply study Patients pregnant plan become pregnant study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>